Twareat Medical Care Co. announced on July 1, 2026 the results of its Ordinary General Assembly Meeting held remotely on June 30, 2026 at 8:05 pm from its Al Khobar headquarters, with 83.07% shareholder attendance. The meeting approved key resolutions including the appointment of BDO Dr. Mohamed Al-Amri & Co. as auditor for specified periods in 2026-2027 with total fees of SAR 530,000 (VAT excluded), authorization for the Board to distribute interim dividends on a semi-annual or quarterly basis for fiscal year 2026, and approval of transactions with Urgent Care Pharmacy Company involving board member Dr. Tariq Mohammed Sulaiman Al-Hamdan with an expected annual value of one million riyals. Additional approvals included the credit risk policy, amendments to the remuneration policy for board members and executive management, and authorization for the Board to exercise Ordinary General Assembly powers for one year.

Original announcement:

Note: The original announcement does not explicitly specify a currency unit. Figures above are reproduced as-is. Please refer to the original announcement for details.

Important Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.